| Generic entry into the regulated Spanish pharmaceutical market I Moreno-Torres, J Puig-Junoy, JR Borrell Review of Industrial Organization 34, 373-388, 2009 | 77 | 2009 |
| Evaluating antitrust leniency programs JR Borrell, JL Jiménez, C García Journal of Competition Law and Economics 10 (1), 107-136, 2014 | 69 | 2014 |
| The drivers of antitrust effectiveness JR Borrell, JL Jimenez Hacienda Publica Espanola, 2008 | 45* | 2008 |
| Pricing and patents of HIV/AIDS drugs in developing countries JR Borrell Applied economics 39 (4), 505-518, 2007 | 36 | 2007 |
| Pharmaceutical price regulation: A study on the impact of the rate-of-return regulation in the UK JR Borrell Pharmacoeconomics 15, 291-303, 1999 | 35 | 1999 |
| Mercado de medicamentos en España: diseño institucional de la regulación y de la provisión pública JRB Arqué, R Nonell Papeles de Economía Española, 113-131, 1998 | 35 | 1998 |
| Fast charging stations: Simulating entry and location in a game of strategic interaction V Bernardo, JR Borrell, J Perdiguero Energy Economics 60, 293-305, 2016 | 34* | 2016 |
| Driving competition in local markets with near-perfect substitutes: an application on the Spanish retail gasoline market J Perdiguero, JR Borrell Empirical Economics 57 (1), 345-364, 2019 | 31* | 2019 |
| The European commission's fight against cartels (1962–2014): A retrospective and forensic analysis JM Ordóñez‐De‐Haro, JR Borrell, JL Jiménez JCMS: Journal of Common Market Studies 56 (5), 1087-1107, 2018 | 29 | 2018 |
| Impact of patents on access to HIV/AIDS drugs in developing countries JR Borrell, J Watal CID Working Paper Series, 2002 | 29 | 2002 |
| Endogenous antitrust: cross-country evidence on the impact of competition-enhancing policies on productivity JR Borrell, M Tolosa Applied Economics Letters 15 (11), 827-831, 2008 | 27 | 2008 |
| La difícil conducción de la competencia por el sector de las gasolinas en España J Perdiguero, JR Borrell Economía Industrial 365, 113-125, 2007 | 21 | 2007 |
| Public demand for medicines, price regulation, and government—industry relationships in spain R Nonell, JR Borrell Environment and Planning C: Government and Policy 19 (1), 119-134, 2001 | 21 | 2001 |
| Spanish competition policy: A case of government's response to domestically perceived problems JR Borrell The Antitrust Bulletin 43 (2), 445-465, 1998 | 20 | 1998 |
| Drug price differentials caused by formularies and price caps JR Borrell International Journal of the Economics of Business 10 (1), 35-48, 2003 | 17 | 2003 |
| Efectos perversos de la regulación farmacéutica en España:¿ hasta dónde se traslada la competencia JR Borrell, A Merino-Castelló Gac Sanit 20 (2), 41-50, 2006 | 14* | 2006 |
| Crímenes y castigos en la lucha contra los cárteles JR Borrell, JL Jiménez González, YE Luna Economía Industrial, 2016, vol. 398, p. 129-144, 2016 | 12 | 2016 |
| Los beneficios de una competencia incipiente: descuentos y bonificaciones a oficinas de farmacia, en Lluís Cases (Ed.) Anuario de la Competencia 2006 JR Borrell, A Merino-Castelló Fundación ICO-Marcial Pons, Madrid, 2007 | 12* | 2007 |
| Redefiniendo los incentivos a la colusión; el programa de la clemencia JRB Arqué, JLJ González, JMO de Haro ICE, Revista de Economía, 2014 | 9 | 2014 |
| ¿ Las patentes, aceleran o retrasan la comercialización de los medicamentos en los países en vías de desarrollo? JRB Arque Cuadernos Económicos de ICE, 2004 | 9* | 2004 |
Juan Luis JiménezUniversidad de Las Palmas de Gran Canaria, ULPGCDirección de correo verificada de ulpgc.es
